SEARCH

SEARCH BY CITATION

References

  • 1
    Jepson RP: Raynaud's phenomenon—a review of the clinical problem. Ann R Coll Surg Engl 9: 3551, 1951
  • 2
    Gifford RW, Hines EA: Raynaud's disease among women and girls. Circulation 16: 10121021, 1957
  • 3
    Harper FE, Maricq HR, Turner RE, Lidman RW, LeRoy EC: A prospective study of Raynaud's phenomenon and early connective tissue disease. Am J Med 72: 883888, 1982
  • 4
    Tan EM, Rodnan GP, Garcia I, Moroi Y, Fritzler MJ, Peebles C: Diversity of antinuclear antibodies in scleroderma: anti-centromere antibody and its relationship to CREST. Arthritis Rheum 23: 617625, 1980
  • 5
    Dictionary of the Rheumatic Diseases. Vol. 1: Signs and Symptoms. New York, Contact Associates International, Ltd., 1982
  • 6
    Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23: 581590, 1980
  • 7
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 12711277, 1982
  • 8
    Ropes MW, Bennett GA, Cobb S, Jacox R, Jessar RA: 1958 revision of the diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 9: 175176, 1958
  • 9
    Bohan A, Peter JB, Bowman RL, Pearson CM: A computer assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 56: 255286, 1977
  • 10
    Rodnan GP: Progressive systemic sclerosis (scleroderma), Arthritis and Allied Conditions. Ninth edition. Edited by DJMcCartyJr. Philadelphia, Lea & Febiger, 1979, pp 762809
  • 11
    Allen EV, Brown GE: Raynaud's disease: a critical review of minimal requisites for diagnosis. Am J Med Sci 183: 187200, 1932
  • 12
    Blain A III, Coller FA, Carver GB: Raynaud's disease—a study of criteria for prognosis. Surgery 29: 387397, 1951
  • 13
    De Takats G, Fowler EF: Raynaud's phenomenon. JAMA 179: 99106, 1962
  • 14
    Porter JM, Bardana EJ, Baur GM, Wesche DH, Andrasch RH, Rosch J: The clinical significance of Raynaud's syndrome. Surgery 80: 756764, 1976
  • 15
    Blunt RJ, Porter JM: Raynaud syndrome. Semin Arthritis Rheum 10: 282308, 1981
  • 16
    Velayos EE, Robinson H, Prociuncula FE, Masi AT: Clinical correlation analysis of 137 patients with Raynaud's phenomenon. Am J Med Sci 262: 347356, 1971
  • 17
    Fritzler MJ, Kinsella TD, Garbutt E: The CREST syndrome: a distinct serologic entity with anticentromere antibodies. Am J Med 69: 520526, 1980
  • 18
    Kallenberg CGM, Wouda AA, The TH: Systemic involvement and immunologic findings in patients with Raynaud's phenomenon. Am J Med 69: 675680, 1980
  • 19
    Steen VD, Ziegler GL, Rodnan GP, Medsger TA Jr: Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis. Arthritis Rheum 27: 125131, 1984
  • 20
    Stevens MB, Hookman P, Siegel CL, Esterly JR, Shulman LE, Hendrik TR: Aperistalsis of the esophagus in patients with connective tissue disorders and Raynaud's phenomenon. N Engl J Med 270: 12181222, 1964
  • 21
    Kallenberg CGM, Pastoor GW, Wouda AA, The TH: Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies. Ann Rheum Dis 41: 382387, 1982
  • 22
    Spencer-Green G, Hess EV: Prospective analysis of nailfold capillary pattern in Raynaud's phenomenon (abstract). Arthritis Rheum (suppl) 25: S127, 1982